Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
35m agoNayax to Report 2026 Q1 Earnings on May 12, 2026
1h agoCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
1h agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
1h agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
1h agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
Bluejay Diagnostics Inc logo

Bluejay Diagnostics Inc

About

Bluejay Diagnostics Inc (NASDAQ:BJDX) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 7 2026
Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial
Mar 12 2026
Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting
Mar 6 2026
Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook
Feb 20 2026
Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised
Feb 17 2026
Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026

Financials

Revenue
$0
Market Cap
$2.02 M
EPS
-15.25

Community Chat

Ask AI

6ix6ixAIEvents